On November 3, 2009, Rigel Pharmaceuticals, Inc. ("Rigel") announced certain financial results for its third quarter and nine months ended September 30, 2009. A copy of Rigel's press release, entitled "Rigel Announces Third Quarter 2009 Financial Results," is furnished pursuant to Item 2.02 as Exhibit 99.1 hereto.

(d) Exhibits.

Exhibit No.                                 Description
99.1          Press Release, dated November 3, 2009, entitled "Rigel Announces Third
              Quarter 2009 Financial Results."

The information in this report, including the exhibit hereto, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Rigel Pharmaceuticals, Inc., whether made before or after the date hereof, regardless of any general incorporation language in such filing.